25 Live Notices for Oxycodone Tenders
Showing 1 to 20
Object: Electronic Auction - Acquisition Of Quetiapine 25 Mg Coated Tablet, Venlafaxine 75 Mg Capsule Prolonged Release, Morphine (Sulfate) 10 Mg Tablet 10 Mg Compressed Oxycodone, 10 Mg Compressed Valproate 500Mg Coated Compressed, Naltrexone (Hydrochloride) 50 Mg Compressed
08 Feb 2025
22 Feb 2025* Price Registration * Quetiapine Acquisition 25 Mg Coated Tablet, Venlafaxine 75 Mg Capsule Prolonged Release, Morphine Sulfate 10 Mg Tablet, 10 Mg Tablet, Oxycodone 10 Mg, Sodium Valproate 500Mg Coated Tablet, Naltrexone Hydrochloride 50 Mg Compressed
Lp Containing Oxycodone 2025
* Price Registration * Intention To Register Prices For The Acquisition Of Fampridine Concentration: 10 Mg, Lysdexamphetamine Dimesilate Concentration: 30 Mg And 70 Mg, Oxcarbazepine Dosage: 300 Mg, Oxycodone Hydrochloride Concentration: 20 Mg, Pharmaceutical Form: Controlled Release, Paroxetine Hydrochloride Dosage: 20 Mg And Pregabalin Concentration: 150 Mg According To Other Specifications Contained In The Terms Of Reference.
Medicines And Dressings
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Pharmaceutical Discount Agreements For Various Active Ingredients Within The Framework Of An Open-House Procedure
Open House Drug Discount Agreements Oxycodone And Naloxone, Atc N02Aa55
Open House Drug Discount Agreements Oxycodone And Naloxone, Atc N02Aa55
Medicines With The Active Ingredient Combination Oxycodone And Naloxone (Atc: N02Aa55)
Completion Of A Non-Excl. Discount Agreement According To § 130A Paragraph 8 Sgb V For Oxycodone, Naloxone (Patent-Free Indication), Atc Code: N02Aa55 For The Period From October 1St, 2023 To September 30Th, 2025
Completion Of A Non-Excl. Discount Agreement According To § 130A Paragraph 8 Sgb V For Oxycodone, Naloxone (Patent-Free Indication), Atc Code: N02Aa55 For The Period From October 1St, 2023 To September 30Th, 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Oxycodone + Naloxone (N02Aa55) As Part Of A So-Called Open House Model.
Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Tenders by Country